Enterprise Therapeutics logo

Enterprise Therapeutics

Dedicated to the development of novel therapies to improve the lives of patients with respiratory disease

13 employees · est. 2014 · Brighton, United Kingdom

VS
Verona Pharma logo

Verona Pharma

Developing life enhancing treatments for chronic respiratory diseases

195 employees · est. 2005 · London, United Kingdom

Verona Pharma is the older company (2014 vs 2005); Verona Pharma is the larger of the two.

Side-by-Side Comparison

Enterprise Therapeutics Verona Pharma
Founded
2014 2005 older
Headquarters
Brighton, United Kingdom London, United Kingdom
Employees
13 195 larger
Industry
Health Care, Health and Wellness Biotechnology, Health and Wellness, Pharmaceutical
Funding Stage
Series B Post Ipo Debt
Total Funding
$68.80M $1.49B
Funding Rounds
7 7
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Respiratory Medicine, Mucus Congestion, COPD, Asthma, Cystic Fibrosis, Drug Development, Disease-modifying Drugs, Lung Infections, Quality Of Life, Respiratory Biology, Ion Channel Pharmacology, University Of Sussex, Biopharmaceuticals Biopharmaceutical Company, Respiratory Diseases, Chronic Conditions, Ensifentrine, Lung Function Improvement, COPD Exacerbations, Clinical-stage, Nasdaq Listed, Management Team, Innovative Therapies, Bronchodilator, Anti-inflammatory Activities, Clinical Trials, London Headquarters, Commercialization
Website
enterprisetherapeutics.com veronapharma.com
Enterprise Therapeutics logo

About Enterprise Therapeutics

Enterprise Therapeutics is a UK-based drug discovery company founded in 2014, dedicated to developing innovative therapies for respiratory diseases. The company's focus lies in addressing conditions such as cystic fibrosis, asthma, and COPD, where mucus congestion in the lungs severely impacts patie...

Verona Pharma logo

About Verona Pharma

Verona Pharma is a clinical-stage biopharmaceutical company with a focus on developing and commercializing innovative therapies for the treatment of chronic respiratory diseases with significant unmet medical needs. The company's product candidate, ensifentrine, has shown potential to be the first t...

We will tell you when either one moves

BounceWatch watches Enterprise Therapeutics and Verona Pharma for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Enterprise Therapeutic... and Verona Pharma — by email.

Frequently Asked Questions

Enterprise Therapeutics — Dedicated to the development of novel therapies to improve the lives of patients with respiratory disease. Verona Pharma — Developing life enhancing treatments for chronic respiratory diseases. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Enterprise Therapeutics has raised $68.80M while Verona Pharma has raised $1.49B.
Enterprise Therapeutics and Verona Pharma operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Enterprise Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Enterprise Therapeutics on 11 Sep 2024, and Verona Pharma on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes